Aptevo Therapeutics | S-1: General form for registration of securities under the Securities Act of 1933
Aptevo Therapeutics | 8-K: Current report
Aptevo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Lamothe Jeffrey G.
Aptevo Therapeutics | 8-K: Current report
Aptevo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Taylor Daphne
Aptevo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Kwon SoYoung
Aptevo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer White Marvin L
Aptevo Therapeutics | 10-K: Annual report
Aptevo Therapeutics | 8-K: Current report
Aptevo Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Armistice Capital, LLC(9.99%),Steven Boyd(9.99%)
Aptevo Therapeutics | 8-K: Current report
Aptevo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Taylor Daphne
Aptevo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Lamothe Jeffrey G.
Aptevo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer White Marvin L
Aptevo Therapeutics | DEFR14A: Definitive proxy statement in connection with contested solicitations
Aptevo Therapeutics | DEFR14A: Definitive proxy statement in connection with contested solicitations
Aptevo Therapeutics | DEF 14A: Definitive information statements
Aptevo Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Aptevo Therapeutics | EFFECT: Others
Aptevo Therapeutics | CORRESP: CORRESP
No Data